Forecasts data is unavailable for this security.
Consensus recommendation
- 19-Sep-24
- 17-Oct-24
- 07-Nov-24
Select bar for recommendation details.
Recommendations | 07-Nov-24 | |
---|---|---|
Buy | 2 | |
Outperform | 2 | |
Hold | 0 | |
Sell | 0 | |
Strong Sell | 0 |
Share price forecast in USD
The 4 analysts offering 12 month price targets for Contineum Therapeutics Inc have a median target of 30.00, with a high estimate of 32.00 and a low estimate of 25.00. The median estimate represents a 63.04% increase from the last price of 18.40.
High | 73.9% | 32.00 |
Med | 63.0% | 30.00 |
Low | 35.9% | 25.00 |
Earnings history & estimates in USD
Average growth rate | +43.22% |
More ▼